Medical use of pharmaceutical combination or composition
US12364700B2 · kind B2 · utility
0Cited by
166References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2023 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Aug 7, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a certain DPP-4 inhibitor for use in combination with metformin in CKD patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.